New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on: December 22,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on:December 22,2023

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on: June 17,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on:June 17,2024

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on: March 25,2024

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on:March 25,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on: January 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on:January 08,2024

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on: May 09,2024

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on:May 09,2024

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie

Updated on: December 25,2023

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie

Updated on:December 25,2023

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024

Researchers develop new method to detect cancerous DNA in lung cancer patients' blood

by European Society for Medical OncologyLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new method of determining the sequence of molecules in DNA can be used to

Updated on: June 11,2024

Researchers develop new method to detect cancerous DNA in lung cancer patients' blood

by European Society for Medical OncologyLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA new method of determining the sequence of molecules in DNA can be used to

Updated on:June 11,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on: November 10,2024

Prostate cancer: Family history, genetics and your risk

by Jessica Saenz,Mayo ClinicCredit: Kampus Production from PexelsIf you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of

Updated on:November 10,2024

Researchers identify possible new combination treatment for advanced melanoma

by University of California, Los AngelesMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A study by researchers at

Updated on: April 22,2024

Researchers identify possible new combination treatment for advanced melanoma

by University of California, Los AngelesMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A study by researchers at

Updated on:April 22,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on: March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on:March 30,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024